Viewing Study NCT01712659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-01-25 @ 12:32 AM
Study NCT ID: NCT01712659
Status: TERMINATED
Last Update Posted: 2023-01-10
First Post: 2012-10-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Ruxolitinib for Adult T-Cell Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T Cell Leukemia, Adult View
None Leukemia, Adult T-Cell View
None T Cell Leukemia, HTLV I Associated View
Keywords:

Keywords

Keyword Brief Keyword Text View
None JAK 1/2 View
None Human T-Cell Lymphotropic Virus 1 View
None HTLV-1 View
None Janus Kinase Inhibitor View